Tumor progression in four mammary epithelial cell lines derived from the same patient.
about
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSTAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasisTranscriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell linesDown-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatmentAbrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesisA novel protease homolog differentially expressed in breast and ovarian cancerMarked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionLess is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.Positive selection of candidate tumor-suppressor genes by subtractive hybridization.The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines.Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptorThe human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesisStructural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.Dysregulating IRES-dependent translation contributes to overexpression of oncogenic Aurora A Kinase.A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate.Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormonesEnhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathwayP53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosisExpression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers.Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.DNA methylation-related vitamin D receptor insensitivity in breast cancer.Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer.Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer.A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell linesDecoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerTissue-type plasminogen activator is a target of the tumor suppressor gene maspin.High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.A polymerase chain reaction-based microsatellite typing assay used for tumor cell line identification.The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancerShort-term primary culture of epithelial cells derived from human breast tumoursDevelopment and characterization of new immortalized human breast cell linesThe microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display methodRe-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines.ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells.Variation in RNA expression and genomic DNA content acquired during cell culture.
P2860
Q21092361-23919946-D946-46FE-AB69-0C44585E63ADQ24300906-0249C775-0A76-41F5-A8C7-306D0E235244Q24337090-09CF231F-BD34-463B-9402-150C40033280Q24562633-C3ECA3F2-D69E-467D-A650-CB34894728BCQ24644884-5EAF693B-44BC-441A-8D61-CDE29A266F49Q24654651-CA8F07B1-761F-418F-B7FC-8B6081D6CE70Q28829301-B7587108-9C57-4623-8831-0A504393DDEBQ30824578-920FE0E4-2DA7-4D3F-80A8-7A4D4EAD0617Q33336307-05BF1B08-8FBB-4FD0-81B6-720C6D86C8A7Q33651543-A3FA7E3A-0579-4E31-86C3-62A70F0F9641Q33804702-D579A815-7EC7-4A66-A90B-D7C1BF0C3149Q33888765-78411210-C076-42F9-A939-E5F14FA1AE65Q33923783-369C9ED4-A88F-470D-8DC0-8793D55AE811Q33944846-1BDC2ECD-A211-4176-81D6-45F7C5D2D7DFQ33948589-57AA5539-F11C-4E3F-BA42-F438619ED8D0Q33974007-57EEAD87-8D3A-4880-86A2-ACBDF18974BCQ34050026-02241DFE-A3F4-422D-A660-EB2CB1B1BE4EQ34157590-FAC1FC2B-E0F5-46AB-8FEB-3E9922BF79F1Q34207195-9CA94DA0-8121-4EB5-828B-57616EB3B88FQ34502681-0EB09F43-BFF5-4B03-B9C4-33B1D757DBA5Q34616517-A1107C68-9470-473D-A1CB-D53F2223DAD7Q34628519-245CAC85-064F-4449-8DCB-BAEAB880F9B0Q34929257-7FF4A305-361D-4443-B1FB-B13251AF1447Q35050479-496258E8-B8CD-4211-8B0E-D8B82FE10664Q35602561-888F9CA8-845C-4DC2-AA38-DEC6B7609A58Q35624809-ECA3A6E7-8CE7-4980-A865-E0951C6F9274Q35626593-1873DF97-BD17-4ECD-894A-A561BAA55B0AQ35693389-090BA2C9-C338-41AE-8C37-5C267D8234ADQ35738498-C0B8FCE5-C1D2-4D95-A22D-E261425FC771Q35759154-77DEAB76-7E4B-44F5-BD20-CB4C5E41B9A1Q35833311-79ADAF71-D8C7-4E8A-91E1-C0282B469DAAQ36110675-B0C39B60-42E7-483E-B785-0B32B6E86A0DQ36115787-E0CF2F07-69B8-4182-BD12-79E4E1E88604Q36254789-EDACA8E5-21C6-4D75-919A-41E4ECB8F30DQ36323769-EB646CE0-8332-4A32-849F-8CC21DE0F5ACQ36437925-78720757-E8E0-499E-A53A-8210152F943CQ36438497-92301D88-5EF3-495F-858F-CA97759B22BFQ36480268-8A5E1CEE-0A35-4612-82A2-249A66123F27Q36621254-8298A1EE-7647-4410-BF4A-056C400211D1Q36694492-05E7A129-0D46-4DA3-8ECD-F8F6238EC243
P2860
Tumor progression in four mammary epithelial cell lines derived from the same patient.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@en
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@nl
type
label
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@en
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@nl
prefLabel
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@en
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@nl
P2093
P4510
P1433
P1476
Tumor progression in four mammary epithelial cell lines derived from the same patient.
@en
P2093
Connolly J
Swisshelm K
Zajchowski D
P304
P407
P577
1990-11-01T00:00:00Z